A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
Crossref DOI link: https://doi.org/10.1186/s13023-015-0297-7
Published Online: 2015-06-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Remenova, Tatiana
Morand, Olivier
Amato, Dominick
Chadha-Boreham, Harbajan
Tsurutani, Scott
Marquardt, Thorsten
Funding for this research was provided by:
Actelion Pharmaceuticals
License valid from 2015-06-19